Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets (2014 - 2016)

Enanta Pharmaceuticals (ENTA) has 3 years of Current Deferred Tax Assets data on file, last reported at $1.1 million in Q2 2016.

• For the quarter ending Q2 2016, Current Deferred Tax Assets fell 34.72% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2016 stood at $1.1 million (down 34.72% YoY), and the FY2015 full-year result was $1.4 million, down 86.99% from the prior year.
• Current Deferred Tax Assets for Q2 2016 stood at $1.1 million, down from $1.6 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $11.2 million in Q2 2014 and bottomed at $1.1 million in Q2 2016.
• The 3-year median for Current Deferred Tax Assets is $1.6 million (2015), against an average of $3.6 million.
• Peak annual rise in Current Deferred Tax Assets reached 17.28% in 2015, while the deepest fall reached 86.99% in 2015.
• A 3-year view of Current Deferred Tax Assets shows it stood at $1.3 million in 2014, then advanced by 17.28% to $1.6 million in 2015, then declined by 27.45% to $1.1 million in 2016.
• The last three Current Deferred Tax Assets figures came in at $1.1 million (Q2 2016), $1.6 million (Q1 2016), and $1.6 million (Q4 2015), per Business Quant data.

Peer Comparison